Skip to main content
NIH funding notice RFA-NS-23-007

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Closed on April 4, 2025.

Posted
September 15, 2022
Close date
April 4, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,470,277 in first-year total cost, median $349,999.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 NV-S (14)]3
  2. Special Emphasis Panel[ZRG1 NV-C (10)]2
  3. Special Emphasis Panel[ZGM1 BBCB-A (SB)]1
  4. Special Emphasis Panel[ZNS1 SRB-R (30)]1

Most frequent institutions

  1. AVENTUSOFT, LLC1
  2. EPIGEN BIOSCIENCES, INC.1
  3. MEDICAL ELUTION DEVICES LLC1
  4. SERENTRIX, LLC1
  5. TREKKA THERAPEUTICS, LLC1
Competing awards under RFA-NS-23-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Nanodroplet Infused Analgesic-Wafer for Transmucosal Opioid-free Treatment of Subacute Oral Pain1R41DE034604-01A1WANG, CHUNTREKKA THERAPEUTICS, LLC, MN$413,298ZRG1
2025Development of Allosteric Uncouplers as Therapeutics for Chronic Pain1R41GM165099-01A1THOMSEN, ALEX ROJAS BIEUNCO THERAPEUTICS LLC, DE$350,000ZNS1
2025Novel Methods for Nicotinic Receptor Modulation in the Treatment of Post-Operative Pain1R41GM165098-01A1MCGEHEE, DANIEL SUTESHEV, VICTOR VEPIGEN BIOSCIENCES, INC., CA$349,999ZRG1
2025An Innovative AI-Powered Wearable Physiological Sensor System for Real-Time Pain Monitoring and Management (PainVitals)1R41GM162038-01KALE, KAUSTUBHAVENTUSOFT, LLC, FL$349,855ZGM1
2024Validating SER-014, a TRPV1 antagonist, to treat endometriosis1R41HD115418-01BHARGAVA, KUMARILSERENTRIX, LLC, PA$384,418ZRG1
2024Chest Tube with Sustained Release of Local Anesthetic Agents for Pain Reduction in Cardiothoracic Surgeries1R41HL176225-01BAKER, AARON BLAIRSTROMBERG, DANIELMEDICAL ELUTION DEVICES LLC, TX$275,752ZRG1
2023Opioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief1R41NS132625-01A1CUI, XINYAN TRACYVANISH THERAPEUTICS INC., PA$346,955ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-NS-23-007: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | ScienceDex | ConductScience